These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 38703506)
1. Angelica sinensis polysaccharide combined with cisplatin reverses cisplatin resistance of ovarian cancer by inducing ferroptosis via regulating GPX4. Guo W; Wang W; Lei F; Zheng R; Zhao X; Gu Y; Yang M; Tong Y; Wang Y Biomed Pharmacother; 2024 Jun; 175():116680. PubMed ID: 38703506 [TBL] [Abstract][Full Text] [Related]
2. miR-324-3p reverses cisplatin resistance by inducing GPX4-mediated ferroptosis in lung adenocarcinoma cell line A549. Deng SH; Wu DM; Li L; Liu T; Zhang T; Li J; Yu Y; He M; Zhao YY; Han R; Xu Y Biochem Biophys Res Commun; 2021 Apr; 549():54-60. PubMed ID: 33662669 [TBL] [Abstract][Full Text] [Related]
3. Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways. Shen W; Liang B; Yin J; Li X; Cheng J Cell Biochem Biophys; 2015 May; 72(1):203-13. PubMed ID: 25510462 [TBL] [Abstract][Full Text] [Related]
4. Dual-Targeted Zeolitic Imidazolate Frameworks Drug Delivery System Reversing Cisplatin Resistance to Treat Resistant Ovarian Cancer. Xing Y; Jing R; Tang X; Jiang Z Int J Nanomedicine; 2024; 19():6603-6618. PubMed ID: 38979533 [TBL] [Abstract][Full Text] [Related]
5. The induction of ferroptosis by impairing STAT3/Nrf2/GPx4 signaling enhances the sensitivity of osteosarcoma cells to cisplatin. Liu Q; Wang K Cell Biol Int; 2019 Nov; 43(11):1245-1256. PubMed ID: 30811078 [TBL] [Abstract][Full Text] [Related]
6. Exosomal miR-4516 derived from ovarian cancer stem cells enhanced cisplatin tolerance in ovarian cancer by inhibiting GAS7. Pan X; Shi X; Zhang H; Chen Y; Zhou J; Shen F; Wang J; Jiang R Gene; 2024 Nov; 927():148738. PubMed ID: 38955306 [TBL] [Abstract][Full Text] [Related]
7. Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving. Wang DY; Li N; Cui YL Cancer Res Treat; 2020 Jul; 52(3):798-814. PubMed ID: 32124583 [TBL] [Abstract][Full Text] [Related]
8. Tripterygium glycosides reverse chemotherapy resistance in ovarian cancer by targeting the NRF2/GPX4 signal axis to induce ferroptosis of drug-resistant human epithelial ovarian cancer cells. Ma B; Zhong Y; Chen R; Zhan X; Huang G; Xiong Y; Tan B Biochem Biophys Res Commun; 2023 Jul; 665():178-186. PubMed ID: 37163938 [TBL] [Abstract][Full Text] [Related]
9. Angelica sinensis polysaccharides promotes apoptosis in human breast cancer cells via CREB-regulated caspase-3 activation. Zhou WJ; Wang S; Hu Z; Zhou ZY; Song CJ Biochem Biophys Res Commun; 2015 Nov; 467(3):562-9. PubMed ID: 26431878 [TBL] [Abstract][Full Text] [Related]
10. Interference with the expression of β-catenin reverses cisplatin resistance in A2780/DDP cells and inhibits the progression of ovarian cancer in mouse model. Zhao H; Wei W; Sun Y; Gao J; Wang Q; Zheng J DNA Cell Biol; 2015 Jan; 34(1):55-62. PubMed ID: 25211326 [TBL] [Abstract][Full Text] [Related]
11. TRIAP1 Inhibition Activates the Cytochrome c/Apaf-1/Caspase-9 Signaling Pathway to Enhance Human Ovarian Cancer Sensitivity to Cisplatin. Zhang TM Chemotherapy; 2019; 64(3):119-128. PubMed ID: 31661694 [TBL] [Abstract][Full Text] [Related]
12. Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression. Ma S; Tan W; Du B; Liu W; Li W; Che D; Zhang G Mol Med Rep; 2016 Apr; 13(4):3342-8. PubMed ID: 26935490 [TBL] [Abstract][Full Text] [Related]
13. Soluble CD40 ligands sensitize the epithelial ovarian cancer cells to cisplatin treatment. Qin L; Qiu H; Zhang M; Zhang F; Yang H; Yang L; Jia L; Qin K; Jia L; Dou X; Cheng L; Sang M; Zhang C; Shan B; Zhang Z Biomed Pharmacother; 2016 Apr; 79():166-75. PubMed ID: 27044825 [TBL] [Abstract][Full Text] [Related]
14. miR-29c-3p inhibits autophagy and cisplatin resistance in ovarian cancer by regulating FOXP1/ATG14 pathway. Hu Z; Cai M; Zhang Y; Tao L; Guo R Cell Cycle; 2020 Jan; 19(2):193-206. PubMed ID: 31885310 [TBL] [Abstract][Full Text] [Related]
15. [Establishment and biological characteristics of a platinum-resistance nude mouse model in epithelial ovarian cancer]. Shi L; Yu H; Zhang W; Li L; Wang Q Zhonghua Fu Chan Ke Za Zhi; 2014 Jul; 49(7):523-30. PubMed ID: 25327735 [TBL] [Abstract][Full Text] [Related]
16. [Inhibition of Topo II alpha gene expression and reversing of drug resistance in multi-drug resistant epithelial ovarian cancer cells induced by RNA interference in vitro]. He J; Li L; Tang BJ; Zhang W; Li DR; Wang Q Zhonghua Fu Chan Ke Za Zhi; 2009 Sep; 44(9):686-90. PubMed ID: 20079182 [TBL] [Abstract][Full Text] [Related]
17. The inhibitory effect of doxycycline on cisplatin-sensitive and -resistant epithelial ovarian cancer. Wu W; Yu LH; Ma B; Xu MJ PLoS One; 2014; 9(3):e89841. PubMed ID: 24598933 [TBL] [Abstract][Full Text] [Related]
18. Roflumilast enhances cisplatin-sensitivity and reverses cisplatin-resistance of ovarian cancer cells via cAMP/PKA/CREB-FtMt signalling axis. Gong S; Chen Y; Meng F; Zhang Y; Li C; Zhang G; Huan W; Wu F Cell Prolif; 2018 Oct; 51(5):e12474. PubMed ID: 30069985 [TBL] [Abstract][Full Text] [Related]
19. Induction of ferroptosis by ATF3 elevation alleviates cisplatin resistance in gastric cancer by restraining Nrf2/Keap1/xCT signaling. Fu D; Wang C; Yu L; Yu R Cell Mol Biol Lett; 2021 Jun; 26(1):26. PubMed ID: 34098867 [TBL] [Abstract][Full Text] [Related]
20. [Biological effect of down-regulating of MTRR gene on cisplatin-resistant ovarian cancer SKOV3 cells in vitro and in vivo studies]. Chen J; Wang Q; Zhang W; Li L Zhonghua Fu Chan Ke Za Zhi; 2016 Feb; 51(2):126-34. PubMed ID: 26917482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]